Tag: In vitro

The journey of a new drug from initial discovery to market approval takes an average of 10-15 years [1.5.5]. A foundational step in this long and expensive process is the pharmacological screening, which systematically tests compounds for therapeutic potential [1.2.1].

In pharmacological research, a lower IC50 value generally indicates a more potent drug, but what is an acceptable IC50 value is highly dependent on the specific biological context and stage of drug development. This metric, which represents the concentration required for 50% inhibition, is not a fixed benchmark but a dynamic measure interpreted alongside other critical factors.